| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 6, 2026 | Sell(S) | 7K | $20.62 | $153K | 509K |
| Feb 4, 2026 | Grant(A) | 73K | — | $0 | 372K |
| Feb 4, 2026 | Grant(A) | 145K | — | $0 | 516K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 4, 2026 | Grant(A) | 440K | $20.43 | $9.0M | 440K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-041500) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Syndax Pharmaceuticals Inc
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.